Association of first-line and second-line antiretroviral therapy adherence.
about
Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South AfricaA cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in AsiaAssociation of knowledge on ART line of treatment, scarcity of treatment options and adherenceMarginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy.Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinicEffect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.Adherence to Highly Active Antiretroviral Therapy Among Children in Ethiopia: A Systematic Review and Meta-analysis
P2860
Q30238931-1163FC5A-C036-418B-8460-CB983C621FCBQ33777513-983BBAF4-4F06-46FF-A76B-D73C56144917Q33868639-F4AB270E-408E-4074-AE25-1768D1DDAC1CQ36063912-483EDAE9-CE14-4E71-9E1A-06A43E38B5B3Q36077969-0EA0EE95-F3EF-4986-8DEE-7E01260B1967Q36109276-F2C4571F-3090-40E2-B952-D5A9CA20A5C8Q36323317-BD481632-A84B-4484-B3FB-5DECD8020A6EQ36460759-1A648A08-7716-4D59-AA35-52B41232E3F5Q38669988-27DCF5BD-63F0-4E24-B647-E25C4F101355Q40337954-1DE31DE4-541A-49E1-AED7-B54B3E480C3DQ52567034-2EBD1CEC-DE4D-4AD5-B45A-5F80EE7FCEDAQ53694036-FAC7E6D5-82DE-437D-B6C5-2CC7D1D9BCCCQ58848755-CB19D12E-8FE8-4214-AF29-BDEC57211D27
P2860
Association of first-line and second-line antiretroviral therapy adherence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of first-line and second-line antiretroviral therapy adherence.
@ast
Association of first-line and second-line antiretroviral therapy adherence.
@en
Association of first-line and second-line antiretroviral therapy adherence.
@nl
type
label
Association of first-line and second-line antiretroviral therapy adherence.
@ast
Association of first-line and second-line antiretroviral therapy adherence.
@en
Association of first-line and second-line antiretroviral therapy adherence.
@nl
prefLabel
Association of first-line and second-line antiretroviral therapy adherence.
@ast
Association of first-line and second-line antiretroviral therapy adherence.
@en
Association of first-line and second-line antiretroviral therapy adherence.
@nl
P2093
P2860
P356
P1476
Association of first-line and second-line antiretroviral therapy adherence.
@en
P2093
Brian W Pence
Calvin E Mmbando
Eileen S Lirhunde
Habib O Ramadhani
John A Bartlett
Lazaro J Masaki
Mary G Minja
Mtumwa S Mwako
Nathan M Thielman
Stephen M Kimani
P2860
P304
P356
10.1093/OFID/OFU079
P577
2014-09-09T00:00:00Z